Qube Research & Technologies LTD Cocrystal Pharma, Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$0.65 - $1.02 $17,234 - $27,045	-26,515 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.01 - $1.25 $26,780 - $33,143	26,515 New	26,515 $28,000
Q2 2021 Aug 13, 2021	SELL	$1.08 - $2.14 $18,647 - $36,949	-17,266 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$1.3 - $2.35 $107,584 - $194,478	-82,757 Reduced 82.74%	17,266 $24,000
Q4 2020 Feb 16, 2021	SELL	$0.8 - $2.16 $101,652 - $274,462	-127,066 Reduced 55.95%	100,023 $136,000
Q3 2020 Nov 12, 2020	BUY	$0.86 - $2.36 $160,432 - $440,255	186,549 Added 460.16%	227,089 $211,000
Q2 2020 Aug 14, 2020	BUY	$0.7 - $1.58 $28,378 - $64,053	40,540 New	40,540 $62,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $17.5M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.